Reckitt Benckiser (RB) in Consumer Health

April 2022

Reckitt Benckiser is the seventh largest consumer health company, with sales mainly in the US and the UK. Over 2018-2021, its OTC sales grew 4% tied to the acquisition of Biofreeze in 2021 and from strong growth in vitamins and dietary supplements during COVID-19. RB’s portfolio is weighted towards a few categories, making brand diversification, customer expansion and sustainability goals critical. The US, the UK and China will drive future growth, particularly in cough/cold and dietary suppleme

USD 570
Request More Information


Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).

This report comes in PPT.


Euromonitor International's report on Reckitt Benckiser Group Plc (RB) delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Reckitt Benckiser Group Plc (RB), while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Reckitt Benckiser Group Plc (RB).

This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWPT analysis of Reckitt Benckiser Group Plc (RB) provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research you can trust:

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Executive summary
Top companies at a glance
Reckitt Benckiser’s global footprint
Company overview
M&A and market momentum drive growth from 2018-21
The US set to be the main contributor to future growth, followed by the UK and China
Reckitt Benckiser to maintain its ranking in the forecast period
RB remains close behind Amway Corp
CCAs in the US sees the greatest competitive overlap
Reckitt Benckiser’s top 10 countries span all regions
The US and the UK are key markets for RB
RB only has one or two brands in four of its top 10 markets
Brand diversification, customer expansion and sustainability goals drive RB’s strategy
Asia Pacific and the Middle East and Africa offer opportunities for RB
RB’s largest revenues are in analgesics, CCA and digestive remedies
Analgesics and CCAs offer USD294 million growth across regions
Schiff is critical for RB’s sales
Dietary supplements is the main source of revenue for most of RB’s top markets in VDS
Most VDS growth in the future will come from the US and China
Key findings
Projected company sales: FAQs (1)
Projected company sales: FAQs (2)

Consumer Health

It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing

See All of Our Definitions

Why buy this report:

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions


If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!